Seehra Jasbir 4
4 · Keros Therapeutics, Inc. · Filed Jan 12, 2021
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2021-01-10+127,200→ 127,200 totalExercise: $70.93Exp: 2031-01-09→ Common Stock (127,200 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on January 7, 2022, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.